Enzo
Enzo Biochem Q1 2022 Revenues Down 8 Percent
The company said its life sciences revenues fell 9 percent from Q1 2021 because of ongoing COVID-19-related shutdowns in Europe, among other reasons.
Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel
Through the partnership, travelers can now schedule COVID-19 diagnostic testing at Enzo locations using CLX Health's TrustAssure platform.
Enzo Biochem Q3 Revenues Nearly Double on Clinical Lab Testing Demand
The recent quarter reflected growing demand for testing services and a steady improvement in sales of its products and services, the firm said.
FDA Grants EUA to Enzo Biochem Sample Collection Kit for COVID-19 Testing
The company said its Ampicollect kit is now available for sample collection as part of COVID-19 testing protocols in the US.
Enzo Biochem Q2 Revenues Up 62 Percent
The company said clinical lab revenues rose 92 percent during the quarter, driven by significant volume and pricing growth due to an improved product mix.
Dec 9, 2020
Enzo Biochem Q1 Revenues Up 42 Percent
Oct 13, 2020
Enzo Biochem Q4 Revenues Down 7 Percent
Jun 8, 2020
Enzo Biochem Q3 Revenues Down 14 Percent
Dec 10, 2019
Enzo Biochem Fiscal Q1 Revenues Down 5 Percent
Oct 15, 2019
Enzo Biochem Fiscal Q4 Revenues Down 8 Percent
Jun 10, 2019